Germany's Merck Receives FDA Acceptance Of New Drug Application For Pimicotinib
MERCK KGAA :SAID ON MONDAY: FDA ACCEPTS NEW DRUG APPLICATION FOR PIMICOTINIB FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR Further company coverage:
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments